With the new label indication, RespiSure-ONE can be administered intramuscularly with a 1 mL injection at processing and a second 1 mL injection at weaning. This vaccination option is in addition to the previously approved one-dose 2 mL injection at processing.

“Providing this flexible dose option demonstrates our commitment to giving veterinarians and producers solutions that fit their needs and help protect pig health,” said Richard Swalla, DVM, Pork Technical Services, Zoetis.

RespiSure-ONE is licensed for the vaccination of healthy swine one day of age or older as an aid in reducing chronic pneumonia caused by Mycoplasma hyopneumoniae (M. hyo). M. hyo is a common bacterial pathogen that infects up to 80% of swine around the world.

It can reduce average daily gain and decrease feed efficiency. The bacteria typically transfers from sow to piglet during lactation as well as from older to younger pigs.

With the new administration option, piglets still get vaccinated on day one, which is important because they may be infected with M. hyo during the first three weeks of life.

“You can be confident that your pigs are getting the protection they need against M. hyo whether you decide to administer two doses or one dose of RespiSure-ONE,” Dr Swalla said.

For more information on RespiSure-ONE and the protocol options, visit www.earlypigvac.com or contact your local Zoetis representative.